RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

The SP dropped because the trader buzzards didnt see any immediate price lift coming, so they sold out and moved on. Why would anyone have expected partnership or buyout news?

<<Neuro, do you think his timelines are realistic? How dire are things? Does it make sense at this juncture to get excited about compounds that will generate revenue after current funds have run out? Was there anything in what he said that offered hope of an upturn in SP?>>

I don't see anything wrong with the clinical trial timelines. As to generating revenues, he specifically referred to partnerships or M&A when they have clinical data. They will have RD data and interim AD data mid-year, plus they will have some tox data on CX701, to go along with CX717's proof of principle. They aren't waiting for revenues from marketed drugs, his premise is that they will be able to partner--or be bought out, at a much better price with that data in hand. He's right--though I raised the point that there is risk in that strategy.

At this point, BP BusDev people and Jim Coleman are very well acquainted--based on all the discussions before the hold, and those that were renewed before the IND rejection. Such "informal" discussions can play with all sorts of scenarios. It's not as if Coleman is waiting by the phone hoping someone will call. The calls flow in both directions. It doesn't mean anything unless a BP decides to ratchet up the seriousness of the discussion. If Cortex does it, it means firesale. I didn't hear anything today to warrant firesale.

NeuroInvestment